RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Golden Biotechnology Stock

Golden Biotechnology P/S 2024

Golden Biotechnology P/S

130.65

Ticker

4132.TWO

ISIN

TW0004132006

As of Aug 25, 2024, Golden Biotechnology's P/S ratio stood at 130.65, a 33.4% change from the 97.94 P/S ratio recorded in the previous year.

The Golden Biotechnology P/S history

Golden Biotechnology Aktienanalyse

What does Golden Biotechnology do?

Golden Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Golden Biotechnology's P/S Ratio

Golden Biotechnology's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Golden Biotechnology's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Golden Biotechnology's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Golden Biotechnology’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Golden Biotechnology stock

What is the price-to-earnings ratio of Golden Biotechnology?

The price-earnings ratio of Golden Biotechnology is currently 130.65.

How has the price-earnings ratio of Golden Biotechnology changed compared to last year?

The price-to-earnings ratio of Golden Biotechnology has increased by 33.4% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Golden Biotechnology high compared to other companies?

Yes, the price-to-earnings ratio of Golden Biotechnology is high compared to other companies.

How does an increase in the price-earnings ratio of Golden Biotechnology affect the company?

An increase in the price-earnings ratio of Golden Biotechnology would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Golden Biotechnology affect the company?

A decrease in the price-earnings ratio of Golden Biotechnology would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Golden Biotechnology?

Some factors that influence the price-earnings ratio of Golden Biotechnology are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Golden Biotechnology pay?

Over the past 12 months, Golden Biotechnology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Golden Biotechnology is expected to pay a dividend of 0 TWD.

What is the dividend yield of Golden Biotechnology?

The current dividend yield of Golden Biotechnology is .

When does Golden Biotechnology pay dividends?

Golden Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Golden Biotechnology?

Golden Biotechnology paid dividends every year for the past 0 years.

What is the dividend of Golden Biotechnology?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Golden Biotechnology located?

Golden Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Golden Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Golden Biotechnology from 8/25/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 8/25/2024.

When did Golden Biotechnology pay the last dividend?

The last dividend was paid out on 8/25/2024.

What was the dividend of Golden Biotechnology in the year 2023?

In the year 2023, Golden Biotechnology distributed 0 TWD as dividends.

In which currency does Golden Biotechnology pay out the dividend?

The dividends of Golden Biotechnology are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Golden Biotechnology

Our stock analysis for Golden Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Golden Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.